Glaucoma: Nursing process (ADPIE)

Glaucoma: Nursing process (ADPIE)

SHRAVAM

SHRAVAM

Gastrointestinal system anatomy and physiology
Fractures: Nursing process (ADPIE)
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Chickenpox (Varicella): Nursing process (ADPIE)
Conjunctivitis: Nursing process (ADPIE)
Hydrocephalus: Nursing process (ADPIE)
Poisoning: Nursing process (ADPIE)
Pyloric stenosis: Nursing process (ADPIE)
Reye syndrome: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Pharmacokinetics - Elimination: Nursing pharmacology
Anthelmintics: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Oxazolidinones: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antimalarials: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Antimycobacterials: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Nitrates: Nursing pharmacology

Notes

GLAUCOMA

KEY POINTS
NOTES
PATIENT REPORT
  • 67-year-old woman
  • Blurred vision, eye pain, headache, nausea
  • Red halos around lights
  • Red eyes
  • Diagnosis: acute angle-closure glaucoma

PATHOPHYSIOLOGY
  • Glaucoma
    • Group of eye conditions associated with increased intraocular pressure (IOP)
    • Aqueous humor drainage restricted 
    • Open-angle
      • Angle between cornea and iris not obstructed but trabecular meshwork is obstructed
      • Primary
      • Secondary
    • Closed-angle/angle-closure
      • Angle between cornea and iris obstructed
      • Primary
      • Secondary
      • Acute
      • Chronic
  • Eye
    • Anterior chamber
    • Posterior chamber
  • Aqueous humor
    • Secreted by ciliary epithelium
    • Flows from posterior chamber to anterior chamber
    • Drains into aqueous veins
    • Controlled production

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • Fundoscopic examination
    • Tonometry
    • Visual acuity
    • Visual field
  • Treatment
    • Medications
    • Laser surgery

ASSESSMENT
  • Extreme pain when moving eyes
  • Seeing red halos around lights
  • Blurry vision
  • Severe headache
  • Feels nauseated
  • Temperature: 98.2 F (36.7 C)
  • Heart rate: 98
  • Respiratory rate: 18
  • Blood pressure: 122/80 mmHg
  • Oxygen saturation: 98% room air
  • Pain: 9/10
  • Eyes nonreactive, dilated, hazy cornea
  • IOP: 44 mmHg

NURSING DIAGNOSES
  • Disturbed visual sensory perception due to increased IOP
  • Pain and nausea related to increased IOP
  • Anxiety related to change in health status 

PLANNING
  • Normal IOP
  • Tolerable pain level 
  • Decrease in nausea
  • Decrease in symptoms 

IMPLEMENTATION
  • Administer medications as prescribed
  • Teach about glaucoma
  • Stress regular eye exams and medication adherence

EVALUATION
  • Pupils equal and reactive to light
  • Cornea less cloudy
  • Pain: 2/10
  • No nausea
  • Vision improving
  • IOP: 21 mmHg
  • Feels less anxious
  • Verbalizes understanding of condition

Transcript

Watch video only

Mrs. Barbara Yao is a 67-year-old female client who was brought by her husband to the emergency department, or ED, with reports of blurred vision, eye pain, a severe headache, and nausea for the past two hours. She states that she sees red halos around lights and you notice her eyes appear red. The ED physician diagnoses her with acute angle-closure glaucoma

Glaucoma refers to a group of eye conditions that are associated with increased pressure in the eye, referred to as intraocular pressure, or IOP. But, before we proceed with glaucoma, first, let’s take a look at a cross-section of the eye. On one side of the lens, we have anterior and posterior chambers filled with the fluid aqueous humor; while on the other side, we have the vitreous body filled with the gel-like vitreous humor. Now, the aqueous humor is secreted by the ciliary epithelium into the posterior chamber, and from here, it flows through the pupil to the anterior chamber. Next, from the anterior chamber, the fluid drains out of the eye through the trabecular meshwork, into the Sclemm’s canal, and eventually into the aqueous veins. Controlled production and drainage result in normal intraocular pressure, which typically ranges from 10 to 20mmHg. 

Now, in glaucoma, drainage of aqueous humor is restricted. As a result, the aqueous humour builds up and pushes against the vitreous body.  This causes intraocular pressure to rise which eventually leads to damage to the optic nerve and the retina. Depending on whether or not the angle between the iris and the cornea is obstructed, glaucoma can be defined as open- or closed-angle. 

In open-angle glaucoma, which is also known as wide-angle glaucoma, the angle between the cornea and the iris is not obstructed but the trabecular meshwork is. This is the most common type of glaucoma and Black individuals, those with advanced age, or a family history are at a higher risk. Now, open-angle glaucoma can be primary, where the cause is unknown, or secondary to another condition that causes decreased drainage of aqueous humor. These causes include a build up of white blood cells such as in the case of intraocular inflammation; red blood cells, in the case of intraocular bleeding; or even parts of the retina in the case of retinal detachment. Whatever the cause, all clients present with a gradual increase in intraocular pressure. Initially, increased intraocular pressure affects the optic nerve to some extent, decreasing only the client’s peripheral vision at first. But chronic elevated intraocular pressure will result in further damage to the optic nerve and surrounding tissue, eventually causing loss of central vision as well. So, the final stage of injury is the complete, irreversible blindness.

On the flip side, in closed-angle glaucoma, which is also known as angle-closure glaucoma, the angle between the cornea and the iris is obstructed so the aqueous humor can’t reach the trabecular meshwork. Again, closed-angle glaucoma can be primary or secondary. In primary cases, the reason is unknown; whereas the secondary cases are typically caused by conditions that affect the retina and decrease oxygen supply to the eye, like diabetes mellitus or central retinal vein occlusion. This lack of oxygen triggers the process called neovascularization, or the formation of new blood vessels. Some of these new blood vessels can grow into the iris and push it forward, subsequently closing the angle and blocking the outflow. Another secondary cause of closed-angle glaucoma are medications called muscarinic blockers, such as atropine. These medications cause mydriasis, or pupil dilation, thus pushing the iris into the angle and reducing the outflow.

Now closed-angle glaucoma can be acute, in which case the blockage causes a rapid and sharp increase in intraocular pressure, and this is an ophthalmologic emergency. These clients typically present with an abrupt onset of severe pain in the affected eye; ciliary flush, or eye redness; headaches; and vomiting. Additionally, they complain of blurry vision and sometimes see colored halos when looking at a light source. On the other hand, in chronic closed-angle glaucoma, the closure develops gradually so the pressure increases slower so it’s less severe. But, over time, it can also cause damage to the optic nerve and result in blindness if left untreated. Next, individuals with chronic glaucoma have a higher risk of developing long-term complications, such as optic atrophy and cataract formation, or clouding of the lens. Finally, chronic closed-angle glaucoma can cause atrophy of muscles that control the diameter of the pupil, leading to permanent dilation.

Important risk factors that can increase the risk of closed-angle glaucoma include anatomic predispositions,  positive family history of glaucoma, older age, and female sex. Also, glaucoma is more common in Asian and Inuit populations. Finally, individuals who have far-sightedness have a higher risk of developing glaucoma because their angle between the cornea and iris is smaller.

Now, the examination of clients with glaucoma typically reveals mid-dilated nonreactive pupils and firm globes, which are often associated with painful eye movements. The diagnosis proceeds with a fundoscopic examination which usually reveals a shallow anterior chamber and a narrow angle between cornea and iris. Additionally, it can reveal “cupping” of the optic disk, which occurs when the tissue around the optic nerve dies, leaving behind an empty space resembling a cup. Next, tonometry can be performed to measure intraocular pressure; while gonioscopy can be performed to evaluate the internal drainage system of the eye, and visual acuity tests can be used to assess and compare visual acuity in each eye. Finally, visual field testing can be ordered to assess the client's peripheral and central vision.

Treatment focuses on medications that decrease the intraocular pressure. This can be done in several ways. First, we can decrease the production of aqueous humor with medications such as beta-adrenergic receptors antagonists, like timolol; and carbonic anhydrase inhibitors, like acetazolamide. Next, we can increase the outflow of aqueous humor with prostaglandin analogs, such as latanoprost. Finally, we can decrease production and increase outflow with medications called alpha-adrenergic agonists, such as epinephrine. Clients who are unresponsive to medications, are candidates for laser interventions.

Sources

  1. "Ackley and Ladwig’s Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care, 13th edition" Mosby (2022)
  2. "Inflammation in Glaucoma: From the back to the front of the eye, and beyond" Prog Retin Eye Res (2021)
  3. "Glaucoma" Med Clin North Am (2021)
  4. "Advanced glaucoma at diagnosis: current perspectives" Eye (Lond) (2020)
  5. "Harrison’s Principles of Internal Medicine, 21st edition" McGraw Hill / Medical (2022)
  6. "The Diagnosis and Treatment of Glaucoma" Dtsch Arztebl Int (2020)
  7. "Glaucoma in Adults-Screening, Diagnosis, and Management: A Review" JAMA (2021)